Logo image of PEAK

HEALTHPEAK PROPERTIES INC (PEAK) Stock Fundamental Analysis

USA - NYSE:PEAK - US42250P1030 - REIT

17.1 USD
+0.35 (+2.09%)
Last: 3/1/2024, 8:04:00 PM
17.1 USD
0 (0%)
After Hours: 3/1/2024, 8:04:00 PM
Fundamental Rating

3

Overall PEAK gets a fundamental rating of 3 out of 10. We evaluated PEAK against 128 industry peers in the Diversified REITs industry. While PEAK is still in line with the averages on profitability rating, there are concerns on its financial health. PEAK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

PEAK had positive earnings in the past year.
In the past year PEAK had a positive cash flow from operations.
Each year in the past 5 years PEAK has been profitable.
Each year in the past 5 years PEAK had a positive operating cash flow.
PEAK Yearly Net Income VS EBIT VS OCF VS FCFPEAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

1.2 Ratios

PEAK has a better Return On Assets (1.94%) than 65.60% of its industry peers.
PEAK has a better Return On Equity (4.79%) than 68.80% of its industry peers.
PEAK's Return On Invested Capital of 2.45% is in line compared to the rest of the industry. PEAK outperforms 47.20% of its industry peers.
PEAK had an Average Return On Invested Capital over the past 3 years of 2.14%. This is in line with the industry average of 3.04%.
The last Return On Invested Capital (2.45%) for PEAK is above the 3 year average (2.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROIC 2.45%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
PEAK Yearly ROA, ROE, ROICPEAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

The Profit Margin of PEAK (13.95%) is better than 68.00% of its industry peers.
In the last couple of years the Profit Margin of PEAK has declined.
PEAK has a Operating Margin (20.53%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of PEAK has declined.
PEAK has a worse Gross Margin (59.28%) than 73.60% of its industry peers.
PEAK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
PEAK Yearly Profit, Operating, Gross MarginsPEAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PEAK is destroying value.
The number of shares outstanding for PEAK remains at a similar level compared to 1 year ago.
PEAK has more shares outstanding than it did 5 years ago.
PEAK has a worse debt/assets ratio than last year.
PEAK Yearly Shares OutstandingPEAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
PEAK Yearly Total Debt VS Total AssetsPEAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that PEAK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.34, PEAK is doing worse than 64.80% of the companies in the same industry.
The Debt to FCF ratio of PEAK is 32.87, which is on the high side as it means it would take PEAK, 32.87 years of fcf income to pay off all of its debts.
PEAK has a Debt to FCF ratio of 32.87. This is comparable to the rest of the industry: PEAK outperforms 52.00% of its industry peers.
PEAK has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of PEAK (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Altman-Z 0.34
ROIC/WACC0.37
WACC6.55%
PEAK Yearly LT Debt VS Equity VS FCFPEAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

PEAK has a Current Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of PEAK (0.14) is worse than 96.80% of its industry peers.
PEAK has a Quick Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of PEAK (0.14) is worse than 96.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
PEAK Yearly Current Assets VS Current LiabilitesPEAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

4

3. Growth

3.1 Past

The earnings per share for PEAK have decreased strongly by -38.86% in the last year.
The earnings per share for PEAK have been decreasing by -23.30% on average. This is quite bad
Looking at the last year, PEAK shows a small growth in Revenue. The Revenue has grown by 5.81% in the last year.
PEAK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.86% yearly.
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%

3.2 Future

PEAK is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.48% yearly.
Based on estimates for the next years, PEAK will show a quite strong growth in Revenue. The Revenue will grow by 8.55% on average per year.
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PEAK Yearly Revenue VS EstimatesPEAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
PEAK Yearly EPS VS EstimatesPEAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

PEAK is valuated quite expensively with a Price/Earnings ratio of 30.54.
Based on the Price/Earnings ratio, PEAK is valued a bit cheaper than the industry average as 61.60% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.89, PEAK is valued at the same level.
With a Price/Forward Earnings ratio of 43.73, PEAK can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, PEAK is valued a bit cheaper than 65.60% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, PEAK is valued a bit more expensive.
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
PEAK Price Earnings VS Forward Price EarningsPEAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

62.40% of the companies in the same industry are more expensive than PEAK, based on the Enterprise Value to EBITDA ratio.
PEAK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 44.73
EV/EBITDA 13.46
PEAK Per share dataPEAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEAK's earnings are expected to decrease with -5.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.02%, PEAK is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.49, PEAK pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.44, PEAK pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.02%

5.2 History

The dividend of PEAK decreases each year by -11.76%.
PEAK has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.76%
Div Incr Years0
Div Non Decr Years0
PEAK Yearly Dividends per sharePEAK Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

215.92% of the earnings are spent on dividend by PEAK. This is not a sustainable payout ratio.
The Dividend Rate of PEAK has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP215.92%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
PEAK Yearly Income VS Free CF VS DividendPEAK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B
PEAK Dividend Payout.PEAK Dividend Payout, showing the Payout Ratio.PEAK Dividend Payout.PayoutRetained Earnings

HEALTHPEAK PROPERTIES INC

NYSE:PEAK (3/1/2024, 8:04:00 PM)

After market: 17.1 0 (0%)

17.1

+0.35 (+2.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-08 2024-02-08/amc
Earnings (Next)N/A N/A
Inst Owners117.78%
Inst Owner Change1.29%
Ins Owners0.15%
Ins Owner Change0%
Market Cap9.36B
Revenue(TTM)2.18B
Net Income(TTM)304.29M
Analysts78.18
Price Target22.19 (29.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.02%
Yearly Dividend1.2
Dividend Growth(5Y)-11.76%
DP215.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.48%
Min EPS beat(2)25.88%
Max EPS beat(2)43.09%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-17.64%
Max EPS beat(4)149.96%
EPS beat(8)6
Avg EPS beat(8)80.62%
EPS beat(12)9
Avg EPS beat(12)65.46%
EPS beat(16)12
Avg EPS beat(16)81.29%
Revenue beat(2)1
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-1.62%
Max Revenue beat(4)0.62%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)3
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-8.89%
PT rev (1m)-1.34%
PT rev (3m)2.46%
EPS NQ rev (1m)-15.62%
EPS NQ rev (3m)-7.95%
EPS NY rev (1m)-12.55%
EPS NY rev (3m)-6.5%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)6.65%
Revenue NY rev (3m)16.7%
Valuation
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
P/S 4.29
P/FCF 44.73
P/OCF 9.78
P/B 1.47
P/tB 1.55
EV/EBITDA 13.46
EPS(TTM)0.56
EY3.27%
EPS(NY)0.39
Fwd EY2.29%
FCF(TTM)0.38
FCFY2.24%
OCF(TTM)1.75
OCFY10.22%
SpS3.99
BVpS11.61
TBVpS11.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROCE 3.1%
ROIC 2.45%
ROICexc 2.47%
ROICexgc 2.68%
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
FCFM 9.59%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
ROICexc(3y)2.16%
ROICexc(5y)1.9%
ROICexgc(3y)2.33%
ROICexgc(5y)2.05%
ROCE(3y)2.71%
ROCE(5y)2.39%
ROICexgc growth 3Y28.26%
ROICexgc growth 5Y4.6%
ROICexc growth 3Y28.51%
ROICexc growth 5Y3.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Debt/EBITDA 5.74
Cap/Depr 99.62%
Cap/Sales 34.25%
Interest Coverage 2.38
Cash Conversion 79.85%
Profit Quality 68.75%
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 0.34
F-Score6
WACC6.55%
ROIC/WACC0.37
Cap/Depr(3y)183.97%
Cap/Depr(5y)234.29%
Cap/Sales(3y)65.04%
Cap/Sales(5y)98.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A
EBIT growth 1Y13.63%
EBIT growth 3Y27.09%
EBIT growth 5Y6.6%
EBIT Next Year208.15%
EBIT Next 3Y49.06%
EBIT Next 5Y31.97%
FCF growth 1Y249.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.21%
OCF growth 3Y8.03%
OCF growth 5Y2.41%

HEALTHPEAK PROPERTIES INC / PEAK FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to PEAK.


Can you provide the valuation status for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (PEAK). This can be considered as Overvalued.


What is the profitability of PEAK stock?

HEALTHPEAK PROPERTIES INC (PEAK) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for PEAK stock?

The Price/Earnings (PE) ratio for HEALTHPEAK PROPERTIES INC (PEAK) is 30.54 and the Price/Book (PB) ratio is 1.47.


Can you provide the financial health for PEAK stock?

The financial health rating of HEALTHPEAK PROPERTIES INC (PEAK) is 1 / 10.